Beneficial effects of retinoic acid on extracellular matrix degradation and attachment behaviour in follicular thyroid carcinoma cell lines

Journal of Endocrinology

Volumn 167, Issue 2, 2000, Pages 229-238

  Havekes, B ^a   Schroder Van der Elst, J P ^a   Van der Pluijm, G ^a   Goslings, B M ^a   Morreau, J ^a   Romijn, J A ^a   Smit, J W A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; MESSENGER RNA; PLASMIN; RETINOIC ACID; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA;

EID: 0033773576     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1670229     Document Type: Article

References (48)

1. Introduction: Adhesion molecules in cancer. Part I
2. The urokinase-type plasminogen activator system in cancer metastasis: A review
3. Human breast cancer cells activate procollagenase-1 and invade type I collagen: Invasion is inhibited by all-trans retinoic acid
4. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control
5. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
6. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
7. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues
8. Induction of expression of the alpha v beta 1 and alpha v beta 3 integrin heterodimers during retinoic acid-induced neuronal differentiation of murine embryonal carcinoma cells
9. Urokinase and its receptor: Marker of malignancy?
10. Growth regulation of normal thyroids and thyroid tumors in man
11. A study of proteasses and protease-inhibitor complexes in biological fluids
12. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor
13. Effects of retinoic acid on protein expression of CD97 and E-cadherin in the human thyroid cell line FTC-133
14. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
15. Plasminogen activation system in active even in thyroid tumors; an immunohistochemical study
16. The role of beta 1 integrins in tumors
17. Retinoids as modulators of tumor cells invasion and metastasis
18. Protein measurement with the Folin phenol reagent
19. Antiproliferative activity of interferon alpha and retinoic acid in SiHa carcinoma cells: The role of cell adhesion
20. Retinoids and cancer: A basis for differentiation therapy
21. Structure and function of the urokinase receptor
22. Localization and expression of integrin subunits in the embryoid bodies of F9 teratocarcinoma cells
23. Acquisition of cell adhesion and induction of focal adhesion kinase of human colon cancer Colo 201 cells by retinoic acid-induced differentiation
24. Matrix metalloproteinases
25. Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion
26. Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1
27. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis
28. Integrins
29. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma
30. Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues
31. Plasminogen activator inhibitors
32. Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis
33. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines
34. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue
35. Role of integrins in the attachment of metastatic follicular thyroid carcinoma cell lines to bone
36. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: Role of the plasmin activation system
37. Embolization for vertebral metastases of follicular thyroid carcinoma
38. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria
39. Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process
40. Increased adhesion of the promyelocytic leukaemia cell line, NB4, to fibronectin and thrombospondin upon all-trans-retinoic acid treatment
41. IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice
42. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone
43. Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro
44. The plasminogen activator/plasmin system
45. alpha2 beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity
46. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells
47. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid
48. Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis